Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001678297 | SCV001895681 | benign | not provided | 2018-11-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26969326) |
Labcorp Genetics |
RCV001678297 | SCV003284306 | benign | not provided | 2023-11-02 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001678297 | SCV004147858 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | TRIOBP: BP4, BS2 |
Breakthrough Genomics, |
RCV001678297 | SCV005277290 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004753380 | SCV005350492 | likely benign | TRIOBP-related disorder | 2024-09-11 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |